
Ertibet 8mg Tablet
Marketer
Soltech Lifesciences
Salt Composition
Betahistine (8mg)
Overview Ertibet 8mg Tablet
Ménière's disease, an inner ear disorder causing vertigo, tinnitus, and hearing loss (often due to excess inner ear fluid), is treated and prevented with Ertibet 8mg Tablets. This medication alleviates symptoms by decreasing fluid buildup. For optimal results, swallow Ertibet 8mg Tablets whole with water, consistently at the same time(s) daily, as directed by your physician. Treatment may last several months; continue taking the medication as prescribed, even after symptom improvement. Common side effects are headache, nausea, and indigestion; stomach pain and bloating may also occur. Taking Ertibet with food may lessen gastrointestinal discomfort. Inform your doctor before use if you have a stomach ulcer, asthma, or hypertension or hypotension. Disclose all other medications to ensure safe use. Consult your doctor if pregnant, planning pregnancy, or breastfeeding.
Uses of Ertibet 8mg Tablet
Managing Meniere's disease
Major Benefits of Ertibet 8mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 8mg Ertibet tablet whole; do not crush, chew, or break it. This medication can be taken with or without food, however, consistent timing is recommended.
Common Side effects of Ertibet 8mg Tablet:
- Headache
- Indigestion
- Nausea
- Stomach pain
- Bloating
How to use Ertibet 8mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. The 8mg Ertibet tablet can be consumed with or without food, though consistent timing is recommended.
How Ertibet 8mg Tablet works:
Histamine analog Ertibet 8mg Tablet enhances inner ear circulation, thereby lessening fluid buildup. This reduction in pressure alleviates the transmission of disruptive signals to the brain, mitigating the nausea, vertigo, and dizziness characteristic of Ménière's disease. The tablet also attenuates nerve impulses originating in the inner ear, providing further symptomatic relief from Ménière's disease.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Ertibet 8mg Tablet and alcohol.
PregnancyCONSULT YOUR DOCTOR
The use of Ertibet 8mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing. Patient consultation with their doctor is recommended.
Breast feedingCONSULT YOUR DOCTOR
Lactation and the use of Ertibet 8mg tablets are likely incompatible. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ertibet 8mg Tablets.
KidneySAFE IF PRESCRIBED
The use of Ertibet 8mg Tablets in individuals with kidney disease appears to pose minimal risk. Preliminary findings indicate dose modification may not be necessary; however, medical advice is recommended.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Ertibet 8mg tablets in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Ertibet 8mg Tablet :
Omit any missed Ertibet 8mg Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Ertibet 8mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Histamine Receptor Agonist |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Behavior Class | Meniere's Disease and Histamine Analogs |
